Interactions of NSAIDs with Diuretics and β-Blockers
- 65 Downloads
Indomethacin attenuates the antihypertensive effect of both thiazide diuretics and β-adrenoceptor blocking drugs. The mechanisms of these interactions are poorly understood but sodium and water retention, suppression of plasma renin activity, alterations in adrenoceptor sensitivity and impaired synthesis of vasodilator prostaglandins may all contribute to this effect. Other non-steroidal anti-inflammatory drugs (NSAIDs) may share this property of indomethacin but sulindac, which is a selective inhibitor of extrarenal prostaglandin synthesis, appears not to. This may have important clinical and theoretical implications. Clinicians must beware of this potential interaction in any patient receiving treatment for hypertension.
NSAIDs may also inhibit the natriuretic response to diuretics with resultant adverse effects in patients with heart failure and other forms of oedema. NSAIDs may also have adverse nephrotoxic effects which may be exacerbated by diuretic therapy.
KeywordsIndomethacin Atenolol Thiazide Prostacyclin Plasma Renin Activity
Unable to display preview. Download preview PDF.
- Armstrong, J.M.; Dusting, G.J.; Moncada, S. and Vane, J.R.: Cardiovascular actions of prostacyclin (PGI2) a metabolite of arachidonic acid which is synthesized by blood vessels. Circulation Research 43(Suppl. 1): 112–119 (1978).Google Scholar
- Birkenhager, W.H.; De Leeuw, P.W.; Wester, A.; Kho, L.T.; Vandongen, R. and Falke, H.E.: Therapeutic effects of β-adrenoceptor blocking agents. Advances in Internal Medicine and Paediatrics 39: 117–134 (1977).Google Scholar
- Chalmers, J.; Ayres, B.; Bune, A.; Graham, J.; West, M. and Wing, L.: Effects of indomethacin, sulindac, naproxen, aspirin and paracetamol in treated hypertensive patients. (Abstract No. 234.) 2nd World Conference on Clinical Pharmacology and Therapeutics (1983).Google Scholar
- Ciabottoni, G.; Pugliese, F.; Cinotti, G.A. and Patrono, C.: Renal effects of anti-inflammatory drugs. European Journal of Rheumatology and Inflammation 3: 210–221 (1980).Google Scholar
- Dollery, C.T.; Patterson, J.W. and Connelly, M.E.: Clinical pharmacology of beta receptor blocking drugs. Clinical Pharmacology and Therapeutics 10: 765–799 (1969).Google Scholar
- Eckstein, J.W.; Wendling, M.G. and Abboud, F.M.: Circulatory responses to noradrenaline after prolonged treatment with chlorothiazide. Circulation Research 28(Suppl. 1): 48–53 (1966).Google Scholar
- Elliott, H.C.: Reduced adrenocortical steroid excretion rates in man following aspirin administration. Metabolism 11: 1015–1018 (1962).Google Scholar
- Harms, H.H.; Gooren, L.; Spoelstra, A.J.G.; Hesse, C. and Verschoor, L.: Blockade of isoprenaline-induced changes in plasma free fatty acids. immunoreactive insulin levels and plasma renin activity in healthy subjects, by propranolol, pindolol, practolol, atenolol, metoprolol and acebutolol. British Journal of Clinical Pharmacology 5: 19–26 (1978).PubMedCrossRefGoogle Scholar
- Jackson, E. and Duff, R.S.: Effect of chlorothiazide on noradrenaline vasoconstriction in man. Clinical Science 24: 24–27 (1963).Google Scholar
- Langer, S.Z.: The role of α and β presynaptic receptors in the regulation of noradrenaline release elicited by nerve stimulation. Clinical Science 51(Suppl. 3): 421–426 (1976).Google Scholar
- Lewis, P.J.: Propranolol — an antihypertensive drug with a central action; in Davies and Reid (Eds) Central Actions of Drugs in Blood Pressure Regulation, pp. 206–213 (Pitman Medical, Tunbridge Wells 1975).Google Scholar
- Lewis, R.V.; Toner, J.M.; Jackson, P.R. and Ramsey, L.E.: Effects of sulindac and indomethacin on the blood pressure of hypertensive patients. (Abstract C44.) Proceedings of the British Pharmacological Society (1985).Google Scholar
- Lopez-Ovejero, J.A.; Weber, M.A.; Drayer, J.I.M.; Sealey, J.E. and Laragh, J.H.: Effects of indomethacin alone and during diuretic or β-adrenoceptor-blockade therapy on blood pressure and the renin system in essential hypertension. Clinical Science and Molecular Medicine 55(Suppl. 4): 203S–205S (1978).Google Scholar
- Salvetti, A.; Pedrinelli, R.; Magagna, A. and Abdel-Haq, B.: The influence of indomethacin on some pharmacological actions of atenolol; in Dunn et al. (Eds). Prostaglandins and the Kidney, pp. 287–295, (Plenum, New York, 1982b).Google Scholar
- Salvetti, A.; Pedrinelli, R.; Magagna, A. and Ugenti, P.: Differential effects of selective and non-selective prostaglandin synthesis inhibition on the pharmacological responses to captopril in patients with essential hypertension. Clinical Science 63: 261S–263S (1982c).Google Scholar